Disagreement between hospital medical records and a structured patient interview on the type and date of the first symptom in cancers of the digestive tract.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 8552851)

Published in Rev Epidemiol Sante Publique on December 01, 1995

Authors

N Malats1, J Belloc, M Gallén, M Porta

Author Affiliations

1: Department d'Epidemiologia, Universitat Autònoma de Barcelona, Spain.

Articles by these authors

Directive of the European Parliament and of the council on the protection of individuals with regard to the processing of personal data and on the free movement of such data. The International Epidemiological Association-IEA European Epidemiological Group. Int J Epidemiol (1995) 2.77

Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia (2007) 2.52

Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up. Diabetes Care (2001) 2.45

Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ (1997) 2.33

Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial. Diabetologia (2002) 2.23

Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry (2007) 2.03

Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia (1996) 1.70

Epidemiology: bridges over (and across) roaring levels. J Epidemiol Community Health (1998) 1.69

Pancreatitis and the risk of pancreatic cancer. Pancreas (1995) 1.64

Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut (2001) 1.62

Poverty, health services, and health status in rural America. Milbank Q (1988) 1.61

Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56

Screening and prevention of diabetic blindness. Acta Ophthalmol Scand (2000) 1.51

Ethics of ignorance: lessons from the epidemiological assessment of the bovine spongioform encephalopathy ("mad cow disease") epidemic. Perspect Biol Med (1998) 1.51

Success and failure at inpatient heroin detoxification. Br J Addict (1989) 1.48

Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health (1991) 1.41

Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care (2001) 1.38

Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health (1998) 1.38

Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet (1982) 1.35

Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract (2006) 1.26

Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators. Eur J Cancer (1994) 1.25

Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetol (2008) 1.16

A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care (2000) 1.15

Clinical assessment of hypermobility of joints: assembling criteria. J Rheumatol (1992) 1.13

Detection and morphology of thymic remnants after video-assisted thoracoscopic extended thymectomy (VATET) in patients with myasthenia gravis. Int Surg (1996) 1.09

Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08

Bone metabolism in type 2 diabetes mellitus. Acta Diabetol (1999) 1.08

Differential activation by Ca2+, ATP and caffeine of cardiac and skeletal muscle ryanodine receptors after block by Mg2+. J Membr Biol (2002) 1.07

Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia (1981) 1.07

Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol (2005) 1.06

Trends in pancreatic cancer mortality in Europe, 1955-1989. Int J Cancer (1994) 1.06

Clinical assessment of dysphagia in early phases of Parkinson's disease. Neurol Sci (2002) 1.05

New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel. Eye (Lond) (2012) 1.04

Video-assisted thoracoscopic extended thymectomy (VATET) in myasthenia gravis. Two-year follow-up in 101 patients and comparison with the transsternal approach. Ann N Y Acad Sci (1998) 1.03

Improvement in survival after myocardial infarction between 1978-85 and 1986-88 in the REGICOR study. (Registre GIroní del COR) registry. Eur Heart J (1995) 1.02

Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis (2005) 1.02

Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators. Int J Cancer (1997) 1.02

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly. Br J Cancer (2003) 1.00

Cytokine stimulated endothelin release from endothelial cells. Life Sci (1991) 0.99

Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Diabet Med (2011) 0.98

A 3-year prospective randomized controlled clinical trial of group care in type 1 diabetes. Nutr Metab Cardiovasc Dis (2005) 0.97

Drug utilization studies: a tool for determining the effectiveness of drug use. Br J Clin Pharmacol (1983) 0.96

Vascular abnormalities in diabetes and their treatment. Trans Ophthalmol Soc U K (1980) 0.95

Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer. J Clin Epidemiol (1998) 0.95

Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes. Diabetologia (2003) 0.94

Causal thinking, biomarkers, and mechanisms of carcinogenesis. J Clin Epidemiol (1996) 0.94

A randomised controlled clinical trial of nurse-, dietitian- and pedagogist-led Group Care for the management of Type 2 diabetes. J Endocrinol Invest (2008) 0.93

Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial. Br J Addict (1990) 0.93

Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose. Diabetes Metab Res Rev (2004) 0.93

Emergency admission for cancer: a matter of survival? Br J Cancer (1998) 0.93

Circulating prostacyclin may be reduced in diabetes. Lancet (1980) 0.92

Myelodysplastic syndromes and malignant solid tumors: analysis of 21 cases. Am J Hematol (1992) 0.92

A randomized controlled trial comparing three invitation strategies in a breast cancer screening program. Prev Med (2001) 0.91

The role of insulin in beta 2-receptor mediated hypokalemia. Clin Endocrinol (Oxf) (1985) 0.91

Evaluation of the locus of control in patients with type 2 diabetes after long-term management by group care. Diabetes Metab (2006) 0.90

Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. II. Ventricular csf concentrations in acute brain post-traumatic syndromes. Eur Neurol (1975) 0.89

Human cancer, carcinogenic exposures and mutation spectra. Mutat Res (1999) 0.89

Carbohydrate counting improves coping ability and metabolic control in patients with Type 1 diabetes managed by Group Care. J Endocrinol Invest (2010) 0.89

Confounding by indication and past clinical trials. Epidemiology (1997) 0.88

Predictors of the interval between onset of symptoms and first medical visit in patients with digestive tract cancer. Int J Oncol (1996) 0.88

The locus of control in patients with Type 1 and Type 2 diabetes managed by individual and group care. Diabet Med (2008) 0.88

Platelet shape change abnormalities in diabetic retinopathy. Diabetologia (1980) 0.88

Anxiety disorders in the joint hypermobility syndrome. Psychiatry Res (1993) 0.88

Association between joint hypermobility syndrome and panic disorder. Am J Psychiatry (1998) 0.88

Rating journals in health care administration. Med Care (1995) 0.87

Nuclear beta-catenin in colorectal tumors: to freeze or not to freeze? Colon Cancer Team at IMAS. J Histochem Cytochem (1999) 0.87

Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators. J Clin Oncol (1995) 0.87

Do we believe what patients say about their neoplastic symptoms? An analysis of factors that influence the interviewer's judgement. Eur J Epidemiol (1996) 0.87

Perceptions of diabetic retinopathy and screening procedures among diabetic people. Diabet Med (2002) 0.87

Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group. Ann Occup Hyg (2000) 0.87

[Agreement between information supplied by the patient and a family member on medical history, consumption of tobacco, alcohol and coffee and diet in cancer of the exocrine pancreas and extrahepatic biliary tract]. Gac Sanit (1996) 0.87

Implementing the Stockholm Treaty on Persistent Organic Pollutants. Occup Environ Med (2002) 0.86

Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake. J Endocrinol Invest (2009) 0.86

DDT and pancreatic cancer. J Natl Cancer Inst (1993) 0.85

Finger-pricking devices: are they less painful than lancets? Diabet Med (1996) 0.85

Re: Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst (1994) 0.84

A study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose. Diabetologia (2003) 0.84

A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol (2011) 0.84

Antibiotic prophylaxis with cefotaxime in gastroduodenal and biliary surgery. Am J Surg (1989) 0.83

Implication of the VGF-derived peptide TLQP-21 in mouse acute and chronic stress responses. Behav Brain Res (2012) 0.83

Feasiblity study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function. Clin Transl Oncol (2006) 0.83

Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer. Gut (2002) 0.83

Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. J Endocrinol (1998) 0.83

Carbamazepine and carbamazepine-10, 11-epoxide concentrations in human brain. Br J Clin Pharmacol (1977) 0.82

Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study. J Endocrinol Invest (2014) 0.82

Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. PANKRAS II Study Group. Dig Dis Sci (1999) 0.82

Protocols for screening and treatment of diabetic retinopathy in Europe. Eur J Ophthalmol (1992) 0.82

Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia (2000) 0.82

Sex as a prognostic factor in gastric cancer. Eur J Cancer (1996) 0.82

[Helicobacter pylori and gastric cancer: relationship with histological subtype and tumor location]. Gastroenterol Hepatol (2005) 0.81

Initial treatment of thyrotoxic Graves' disease with methimazole: a randomized trial comparing different dosages. J Endocrinol Invest (1987) 0.81

Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose. Acta Diabetol (2001) 0.81

A study of central serotoninergic activity in healthy subjects and patients with Type 2 diabetes treated by traditional one-to-one care or Group Care. J Endocrinol Invest (2010) 0.80

Pharmacoepidemiology in practice. Current status and future trends. Drug Saf (1995) 0.80

Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia (2002) 0.80

Calcification of lymph node metastases from prostate carcinoma after hormonal treatment: a case report. Prostate (1997) 0.80

Is fixation during gastric banding necessary? A randomised clinical study. Obes Surg (2011) 0.80